Research lines
Click on a persons name for more information regarding his/her research
Medical Oncology research lines
PI: Liesbeth de Vries, Head of the Department of Medical Oncology
PI: Steven de Jong
- Understanding chemosensitivity of testicular germ cell tumors
- Inducing apoptosis and inhibiting pro-survival to enhance drug efficacy in cancer
-
Identifying novel drugable pathways in ovarian and cervical cancer
PI: Frank Kruyt
- Targeted therapy: apoptosis
- Biology of cancer stem cells: novel therapeutic opportunities
PI: Marcel van Vugt
- DNA damage checkpoint pathways in cancer
PI: Geke Hospers
- Exploring innovative imaging techniques to visualize drug targets.
- Gynaecological malignancies, gastrointestinal stromal tumors and palliative care
- Exploring novel rational treatment options to enhance therapeutic efficacy
- Chemokines and cancer progression
Gynaecological Oncology research lines
PI: Ate van der Zee, Head of the department of Gynaecological Oncology
PI: Bea Wisman
- Improvement of the current population-based cervical cancer screening
-
Identification of novel genes and pathways in the response to therapy
Last modified: | 29 January 2013 4.41 p.m. |